Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
17 p, 367.8 KB New Antibiotics for Staphylococcus aureus Infection : An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) / Esposito, Susanna (Pediatric Clinic. Pietro Barilla Children's Hospital. Department of Medicine and Surgery. University Hospital of Parma) ; Blasi, Francesco (Ca' Granda Ospedale Maggiore Policlinico Milano) ; Curtis, Nigel (Department of Infectious Diseases. The Royal Children's Hospital Melbourne) ; Kaplan, Sheldon (Division of Infectious Diseases. Department of Pediatrics. Baylor College of Medicine) ; Lazzarotto, Tiziana (IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Meschiari, Marianna (Azienda Ospedaliero-Universitaria of Modena) ; Mussini, Cristina (Azienda Ospedaliero-Universitaria of Modena) ; Peghin, Maddalena (Infectious and Tropical Diseases Unit. Department of Medicine and Surgery. University of Insubria-ASST-Sette Laghi) ; Rodrigo Gonzalo de Líria, Carlos (Institut Germans Trias i Pujol) ; Vena, Antonio (IRCCS Ospedale Policlinico San Martino) ; Principi, Nicola (Università degli Studi di Milano) ; Bassetti, Matteo (IRCCS Ospedale Policlinico San Martino) ; Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública
Staphylococcus aureus is an extremely virulent pathogen that is capable of quickly evolving and developing antibiotic resistance. To overcome this problem, new antibiotics have been developed. Some of these have been licenced for use in clinical practice, mainly for the treatment of adults with acute skin and soft tissue infections, in addition to both community-acquired pneumonia (CAP) and nosocomial pneumonia (hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia). [...]
2023 - 10.3390/antibiotics12040742
Antibiotics, Vol. 12 Núm. 4 (april 2023) , art. 742  
2.
16 p, 1.2 MB Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers / Chereau, Fanny (Université Paris-Saclay) ; Madec, Yoann (Institut Pasteur) ; Sabin, Caroline A (Research Department of Infection and Population Health (Regne Unit)) ; Obel, Niels (Copenhagen University Hospital Rigshospitalet) ; Ruiz-Mateos, Ezequiel (Instituto de Biomedicina de Sevilla) ; Chrysos, Georgios (Tzaneio General Hospital of Piraeus) ; Fidler, Sarah (Imperial College (Regne Unit)) ; Lehmann, Clara (University of Cologne and German Center for Infection Research) ; Zangerle, Robert (DMedical University Innsbruck) ; Wittkop, Linda (University Bordeaux) ; Reiss, Peter (Stichting HIV Monitoring) ; Hamouda, Osamah (Robert Koch Institute) ; Estrada Perez, Vicente (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Leal, Manuel (Instituto de Biomedicina de Sevilla) ; Mocroft, Amanda (Research Department of Infection and Population Health (Regne Unit)) ; García de Olalla, Patricia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Ammassari, Adriana (Istituto Nazionale Malattie Infettive) ; D'Arminio Monforte, Antonella (University Hospital (Itàlia)) ; Mussini, Cristina (University of Modena and Reggio Emilia) ; Segura, Ferran (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Castagna, Antonella (San Raffaele Vita Salute University) ; Cavassini, Matthias (Lausanne University Hospital) ; Grabar, Sophie (Institut Pierre Louis d'Epidémiologie et de Santé Publique) ; Morlat, Philippe (Université de Bordeaux) ; De Wit, Stéphane (Université Libre de Bruxelles) ; Lambotte, Olivier (Université Paris Sud) ; Meyer, Laurence (Université Paris-Saclay) ; Universitat Autònoma de Barcelona
HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretroviral therapy (ART), a small number of whom will eventually lose this ability to control HIV viremia. [...]
2017 - 10.1371/journal.pone.0173893  
3.
11 p, 679.0 KB Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved? / Jarrin, Inma (Instituto de Salud Carlos III) ; Pantazis, Nikos (Athens University Medical School, Athens, Greece) ; Dalmau, Judith (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Phillips, Andrew N. (Research Department of Infection and Population Health) ; Olson, Ashley (Medical Research Council Clinical Trials Unit, University College London, London, UK) ; Mussini, Cristina (Institute of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy) ; Boufassa, Faroudy (Univ Paris-Sud, Le Kremlim Bicetre) ; Costagliola, Dominique (INSERM, Paris, France) ; Porter, Kholoud (Medical Research Council Clinical Trials Unit, University College London, London, UK) ; Blanco, Julià (Universitat de Vic - Universitat Central de Catalunya) ; Del Amo, Julia (Instituto de Salud Carlos III) ; Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
This article compares trends in CD4 + T-cell recovery and proportions achieving optimal restoration (≥500 cells/μl) after viral suppression following combination antiretroviral therapy (cART) initiation between rapid and nonrapid progressors. [...]
2015 - 10.1097/QAD.0000000000000805
AIDS, Vol. 29 (october 2015) , p. 2323-2333  

See also: similar author names
2 Mussini, C.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.